Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Gilteritinib

5f233acf-1068-503b-b29a-10e9deaaa6fe · FDA Approved · targets FLT3

Gilteritinib

MeasuredReference

Gilteritinib targets RET, TYK1_LTK, ROS_ROS1.

Primary targets

RETTYK1_LTKROS_ROS1ALKFLT3

Top hallmarks

No hallmark data.

Top pathways disrupted

  • apical junction13.8k
  • allograft rejection13.0k
  • pi3k akt mtor signaling12.6k

Resistance landscape — Gilteritinib

MeasuredReference

10 known oncogenic variants exist on Gilteritinib's top targets — see detail for inhibition impact.

Open in new tab